NervGen Pharma Corp. (NGEN)
NASDAQ: NGEN · Real-Time Price · USD
1.880
+0.020 (1.08%)
At close: Jul 10, 2026, 4:00 PM EDT
1.926
+0.046 (2.43%)
After-hours: Jul 10, 2026, 7:54 PM EDT
NervGen Pharma Market Cap
NervGen Pharma has a market cap or net worth of $199.66 million as of July 10, 2026. Its market cap has increased by 1.16% in one year.
Market Cap
199.66M
Enterprise Value
187.80M
1-Year Change
1.16%
Ranking
Category
Stock Price
$1.88
Market Cap Chart
Since April 3, 2019, NervGen Pharma's market cap has increased from $37.43M to $199.66M, an increase of 433.43%. That is a compound annual growth rate of 25.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 199.66M | -55.21% |
| Dec 31, 2025 | 445.73M | 190.81% |
| Dec 31, 2024 | 153.27M | 26.05% |
| Dec 29, 2023 | 121.60M | 74.14% |
| Dec 30, 2022 | 69.83M | -27.73% |
| Dec 31, 2021 | 96.62M | 58.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 3, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Outlook Therapeutics | 204.26M |
| Tonix Pharmaceuticals Holding | 203.72M |
| Alector | 203.18M |
| Immunic | 201.19M |
| Equillium | 199.16M |
| Humacyte | 197.70M |
| Acumen Pharmaceuticals | 197.18M |
| Caribou Biosciences | 192.41M |